Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 7;16(10):e71000.
doi: 10.7759/cureus.71000. eCollection 2024 Oct.

Outpatient Prescribing Patterns for Uncomplicated Cystitis in Premenopausal Women With and Without an Allergy to Guideline-Recommended Antimicrobials: A Retrospective Analysis

Darcy A Davis  1 , Jaime A Foushee  2 , Amber Stroupe  3 , Shannon S Tiebout  4 , Samantha Rikabi  4 , Miles Lane  5
Affiliations

Outpatient Prescribing Patterns for Uncomplicated Cystitis in Premenopausal Women With and Without an Allergy to Guideline-Recommended Antimicrobials: A Retrospective Analysis

Darcy A Davis et al. Cureus. .

Abstract

Objective: To determine if premenopausal women 18 to 50 years of age with uncomplicated cystitis who have an allergy to a guideline-recommended antimicrobial agent are less likely to receive guideline-preferred treatment compared to women without an allergy.

Methods: An electronic medical record report was used to identify females between the ages of 18-50 with a diagnostic code for acute uncomplicated cystitis at outpatient visits between December 1, 2017, through December 31, 2021. Patients with complicated urinary tract infections or pyelonephritis were excluded. After identifying the eligible encounters, a retrospective chart review was used to collect demographic information, known antimicrobial allergies, urinalysis and culture results, and prescribed antimicrobials. The primary outcome was a receipt of a guideline-preferred antimicrobial. Secondary outcomes included fluoroquinolone utilization and resistance patterns, as well as subgroup analyses of patients with specific allergies to guideline-preferred agents.

Results: A total of 496 patient encounters were screened for inclusion, with 165 meeting the inclusion criteria. Of those, 38 encounters were identified as having a documented antimicrobial allergy (23%) to a guideline-recommended agent. Demographic and clinical characteristics were similar between patients with and without antimicrobial allergies, except for race. Beta-lactam allergies were the most frequently documented antimicrobial allergy. All 165 patients received a guideline-recommended therapy, and 92 received a guideline-preferred agent (56%). Patient encounters without an antimicrobial allergy were numerically but not significantly more likely to receive guideline-preferred therapy (75 of 127 patients, 59%) compared to those with an allergy (17 of 38 patients, 45%; p=0.12). Patient encounters with an antimicrobial allergy were significantly more likely to receive a fluoroquinolone (FQ) prescription (n=6/38, 16%) compared to those without allergies (n=2/127, 1.6%; p=0.002). A subgroup analysis of patients with an allergy to a preferred agent was statistically less likely to receive a guideline-preferred treatment and more likely to receive an alternative agent. No statistical differences in other secondary outcomes were observed.

Conclusion: Premenopausal women with a documented antimicrobial allergy were statistically more likely to receive fluoroquinolone. Prescribers may be less likely to select a guideline-preferred treatment where antimicrobial allergies exist. Providers should be educated on evidence-based treatment within this population.

Keywords: antimicrobial allergy; evidence-based medicine; guideline-recommended antimicrobials; uncomplicated cystitis; urinary tract infection.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Spartanburg Regional Healthcare System Institutional Review Board issued approval 1711429-1. The study was approved by the Spartanburg Regional Healthcare System Institutional Review Board (approval number 1711429-1). Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Consort diagram for the target population
ICD: International Classification of Diseases, UTI: Urinary tract infection, UA: Urinalysis.
See this image and copyright information in PMC

References

    1. Clinical practice. Acute uncomplicated urinary tract infection in women. Fihn SD. N Engl J Med. 2003;349:259–266. - PubMed
    1. Urinary tract infection: self-reported incidence and associated costs. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Ann Epidemiol. 2000;10:509–515. - PubMed
    1. The etiology of urinary tract infection: traditional and emerging pathogens. Ronald A. Am J Med. 2002;113:14–19. - PubMed
    1. Population-based epidemiologic analysis of acute pyelonephritis. Czaja CA, Scholes D, Hooton TM, Stamm WE. Clin Infect Dis. 2007;45:273–280. - PubMed
    1. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Echols RM, Tosiello RL, Haverstock DC, Tice AD. Clin Infect Dis. 1999;29:113–119. - PubMed